It says something about the hype around ex-OpenAI executive Mira Murati’s new startup, Thinking Machines Lab, that when ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
Zacks Small Cap Research on MSN12h
MIRA Makes Another Pain Management StrideMIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company that focuses on the development and commercialization of a new molecular synthetic ...
Mira Costa (7-2, 1-0) had a chance to get on the board in the second inning, loading the bases with no outs. However, ...
Mira Andreeva, the 9th seed at the Indian Wells tournament, delivered a stunning performance that saw her defeat 23rd seed Elina Svitolina with a score of 7-5, 6-3, propelling her into the semifinals.
MIRA Pharmaceuticals (MIRA) announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback